ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Bristol Myers Squibb Announces Dividend

September 9, 2021 GMT

NEW YORK--(BUSINESS WIRE)--Sep 9, 2021--

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of forty-nine cents ($0.49) per share on the $.10 par value common stock of the company. The dividend is payable on November 1, 2021 to stockholders of record at the close of business on October 1, 2021.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable December 1, 2021 to stockholders of record at the close of business on November 9, 2021.

ADVERTISEMENT

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

ADVERTISEMENT

corporatefinancial-news

View source version on businesswire.com:https://www.businesswire.com/news/home/20210909005993/en/

CONTACT: Media:

media@bms.comInvestors:

Nina Goworek, 908-673-9711,nina.goworek@bms.com

Karen Wheeler, 609-252-3396,karen.wheeler@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Bristol Myers Squibb

Copyright Business Wire 2021.

PUB: 09/09/2021 04:16 PM/DISC: 09/09/2021 04:16 PM

http://www.businesswire.com/news/home/20210909005993/en